Drug Resistance and Therapeutic Durability
Therapeutic resistance presents a major challenge in chronic metabolic treatment. Altered adaptive signaling pathways reduce long-term drug responsiveness. Rising drug tolerance necessitates molecular redesign and combination approaches. Managing pathway redundancy improves treatment sustainability. Understanding resistance evolution guides next-generation therapeutic strategies.
Therapeutic Longevity Challenges:
- Resistance Mechanism Mapping
- Adaptive Signaling Control
- Sustained Efficacy Design